Have a personal or library account? Click to login
CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort Cover

CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort

Open Access
|Mar 2025

Figures & Tables

Figure 1:

Heatmap of the clinical, molecular and treatment response data in a cohort of 55 pediatric patients with B-ALL a white blood cell count; b copy number alterations; c prednisolone good response; d prednisolone poor response; e induction failure
Heatmap of the clinical, molecular and treatment response data in a cohort of 55 pediatric patients with B-ALL a white blood cell count; b copy number alterations; c prednisolone good response; d prednisolone poor response; e induction failure

Clinically relevant alterations in the patients with relapse

Copy number alterationsSingle nucleotide variants
No.aSample typeAneuploidy/Hybrid transcriptTP53EBF1CDKN2A/2BPAX5ETV6CREBBPNRASMSH2FLT3
4Dghigh-hyperdiploidy-/--/--/--/--/----+
Relapsehigh-hyperdiploidy-/--/--/--/--/-++--
10Dghigh-hyperdiploidy-/--/dup-/--/--/-+---
Relapsehigh-hyperdiploidy-/del-/dup-/--/--/-+---
32DgBCR::ABL1-/--/--/delb-/delb-/-----
RelapseBCR::ABL1-/--/--/--/--/-+-+-
35Dg -/--/--/--/--/-+c+--
Relapse -/--/--/del-/--/-+c---
36Dg -/del-/del-/--/--/del----
Relapse -/del-/del-/--/--/del----
Language: English
Page range: 5 - 12
Published on: Mar 6, 2025
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year

© 2025 E Krstevska Bozhinovikj, N Matevska-Geshkovska, M Staninova Stojovska, E Gjorgievska, A Jovanovska, S Kocheva, A Dimovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.